-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Abivax, Raises Price Target to $155

Benzinga·07/02/2026 11:42:42
Listen to the news
Truist Securities analyst Gregory Renza maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price target from $135 to $155.